Goodwill Pharma Plc. has significantly expanded its production and warehouse capacity
Goodwill Pharma Plc. has expanded its warehouse capacity, built a research, development and innovation laboratory, a new central office, and a pharmaceutical manufacturing plant in Szeged. The investment, worth almost 5 billion forints, was handed over on Thursday.
Ferenc Jójárt, the CEO of the Szeged company, said at the ceremony that Goodwill Pharma is proof of how a multinational pharmaceutical company can be built from a rural town in Hungary.
Between June 2022 and the end of November last year, developments were implemented at three locations with 1.767 billion forints of conditionally non-refundable EU and domestic support within the framework of the Hungarian Multi Program.
The company has developed a logistics center sufficient to store 4-5 thousand pallets of medicines. It has built a manufacturing plant that meets pharmaceutical industry standards, to which the first machines have already arrived, so the first Szeged-manufactured medicines may be produced at the company by the end of the year or early next year.
The company has established a new pharmaceutical laboratory to expand its research and development activities, and has also developed a new office building in the city center of Szeged – the CEO explained the details of the developments.
Related news
OMV is starting to distribute medicines at nearly 100 filling stations in Hungary
Since spring, over-the-counter medicines have been available at 99 OMV…
Read more >Related news
Food industry sales prices rose by 6.1 percent
In February 2025, industrial producer prices exceeded those of the…
Read more >Real wages are rising, confidence is growing, retail sales are increasing
The dynamic increase in wages continued in January, Sándor Czomba,…
Read more >German retail sales increase in February
German retail sales grew in February, instead of stagnating, as…
Read more >